MSc. Amaylid Arteaga García, director of the National Center for Clinical Trials Coordination. Photo: Roberto Garaycoa / Cubadebate.
–
The MSc. Amaylid Arteaga García, director of the National Center for Clinical Trials Coordination, assesses the quality of Phase III of the vaccination candidates Soberana 02 and Abdala that are advancing in Havana, Santiago de Cuba, Granma and Guantánamo.
Listen here
– .
Related posts:
Ouch! India discovers antibiotic resistant "super germ"
A picture of rotten blood bags and a clinic without a license ... a disaster in a private hospital i...
COVID-19: FAC reveals 198 new cases, Taweesil-2 test results NBT broadcaster is not COVID-addicted
National Center for Mental Health Promotion Adds Addiction to Strategic Priorities
